BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 25400133)

  • 21. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
    Yin X; Latif R; Bahn R; Tomer Y; Davies TF
    Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study.
    Sabini E; Mazzi B; Profilo MA; Mautone T; Casini G; Rocchi R; Ionni I; Menconi F; Leo M; Nardi M; Vitti P; Marcocci C; Marinò M
    Thyroid; 2018 Mar; 28(3):386-394. PubMed ID: 29336220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TSH receptor antibody titers measured with a third-generation assay did not reflect the activity of Graves' ophthalmopathy in untreated Japanese Graves' disease patients.
    Mukasa K; Yoshimura Noh J; Kouzaki A; Ohye H; Kunii Y; Watanabe N; Yoshihara A; Matsumoto M; Suzuki M; Ito K
    Endocr J; 2016; 63(2):151-7. PubMed ID: 26581710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of TSH receptor antibody, thyroid stimulating antibody, and thyroid blocking antibody with clinical activity score and degree of severity of Graves ophthalmopathy.
    Subekti I; Boedisantoso A; Moeloek ND; Waspadji S; Mansyur M
    Acta Med Indones; 2012 Apr; 44(2):114-21. PubMed ID: 22745141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum concentrations of adiponectin and resistin in hyperthyroid Graves' disease patients.
    Sieminska L; Niedziolka D; Pillich A; Kos-Kudla B; Marek B; Nowak M; Borgiel-Marek H
    J Endocrinol Invest; 2008 Sep; 31(9):745-9. PubMed ID: 18997483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum concentrations of HGF and IL-8 in patients with active Graves' orbitopathy before and after methylprednisolone therapy.
    Nowak M; Siemińska L; Karpe J; Marek B; Kos-Kudła B; Kajdaniuk D
    J Endocrinol Invest; 2016 Jan; 39(1):63-72. PubMed ID: 26062519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased nerve growth factor levels in hyperthyroid Graves' ophthalmopathy highlighting the role of neuroprotective factor in autoimmune thyroid diseases.
    Molnár I; Bokk A
    Cytokine; 2006 Aug; 35(3-4):109-14. PubMed ID: 17008110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of clinical course with thyroid-stimulating immunoglobulin in Graves' ophthalmopathy in Mongolians.
    Bayarmunkh O; Ganbold C; Das S; Davaatseren U; Minjuurdorj NE; Jav S
    PLoS One; 2022; 17(11):e0277055. PubMed ID: 36395261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased serum VEGF and b-FGF in Graves' ophthalmopathy.
    Ye X; Liu J; Wang Y; Bin L; Wang J
    Graefes Arch Clin Exp Ophthalmol; 2014 Oct; 252(10):1639-44. PubMed ID: 24867311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IGF1 deficiency in newly diagnosed Graves' disease patients.
    Martin S; Sirbu A; Betivoiu M; Florea S; Barbu C; Fica S
    Hormones (Athens); 2015; 14(4):651-9. PubMed ID: 26188228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased percentage of L-selectin+ and ICAM-1+ peripheral blood CD4+/CD8+ T cells in active Graves' ophthalmopathy.
    Pawlowski P; Mysliwiec J; Stasiak-Barmuta A; Bakunowicz-Lazarczyk A; Gorska M
    Folia Histochem Cytobiol; 2009; 47(1):29-33. PubMed ID: 19419934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered expression profile of BAFF receptors on peripheral blood B lymphocytes in Graves' disease.
    Wang X; Huang J; Zhang A; Fang C; Ma Q; Jiang P
    BMC Endocr Disord; 2021 Apr; 21(1):88. PubMed ID: 33926416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms.
    Daroszewski J; Pawlak E; Karabon L; Frydecka I; Jonkisz A; Slowik M; Bolanowski M
    Eur J Endocrinol; 2009 Nov; 161(5):787-93. PubMed ID: 19734241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavior of soluble intercellular adhesion molecule-1 and endothelial-leukocyte adhesion molecule-1 concentrations in patients with Graves' disease with or without ophthalmopathy and in patients with toxic adenoma.
    De Bellis A; Bizzarro A; Gattoni A; Romano C; Di Martino S; Sinisi AA; Abbadessa S; Bellastella A
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2118-21. PubMed ID: 7541801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between serum cholesterol and Graves' orbitopathy (GO): a confirmatory study.
    Lanzolla G; Sabini E; Profilo MA; Mazzi B; Sframeli A; Rocchi R; Menconi F; Leo M; Nardi M; Vitti P; Marcocci C; Marinò M
    J Endocrinol Invest; 2018 Dec; 41(12):1417-1423. PubMed ID: 29923059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum BAFF concentrations in patients with Graves' disease and orbitopathy before and after immunosuppressive therapy.
    Vannucchi G; Covelli D; Currò N; Dazzi D; Maffini A; Campi I; Bonara P; Guastella C; Pignataro L; Ratiglia R; Beck-Peccoz P; Salvi M
    J Clin Endocrinol Metab; 2012 May; 97(5):E755-9. PubMed ID: 22399512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipidomic differentiation of Graves' ophthalmopathy in plasma and urine from Graves' disease patients.
    Byeon SK; Park SH; Lee JC; Hwang S; Ku CR; Shin DY; Yoon JS; Lee EJ; Moon MH
    Anal Bioanal Chem; 2018 Nov; 410(27):7121-7133. PubMed ID: 30135996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of serum antibodies against three eye muscle antigens and the connective tissue antigen collagen XIII in patients with Graves' disease with and without ophthalmopathy: correlation with clinical features.
    Gopinath B; Musselman R; Adams CL; Tani J; Beard N; Wall JR
    Thyroid; 2006 Oct; 16(10):967-74. PubMed ID: 17042681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum antibodies to collagen XIII: a further good marker of active Graves' ophthalmopathy.
    De Bellis A; Sansone D; Coronella C; Conte M; Iorio S; Perrino S; Battaglia M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):24-9. PubMed ID: 15638866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exophthalmos in a young woman with no graves' disease - a case report of IgG4-related orbitopathy.
    Erdei A; Steiber Z; Molnar C; Berenyi E; Nagy EV
    BMC Ophthalmol; 2018 Jan; 18(1):5. PubMed ID: 29329570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.